Metabolic surgery and cancer

Cancer

Volumn 117, Issue 9, 2011, Pages 1788-1799

  Ashrafian, Hutan ^a   Ahmed, Kamran ^a   Rowland, Simon P ^a   Patel, Vanash M ^a   Gooderham, Nigel J ^a   Holmes, Elaine ^a   Darzi, Ara ^a   Athanasiou, Thanos ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

bariatric surgery; cancer; metabolic surgery; oncology

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; GASTROINTESTINAL HORMONE; INSULIN RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SEX HORMONE; SIALIC ACID; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADAPTIVE IMMUNITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BARIATRIC SURGERY; CANCER INCIDENCE; CANCER PREVENTION; CELL ENERGY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RISK REDUCTION; SURGICAL APPROACH; SURGICAL TECHNIQUE; WEIGHT REDUCTION;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; NEOPLASMS; OBESITY;

EID: 79955441997     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25738     Document Type: Review

References (118)

1. World Health Organization. Obesity and Overweight Fact Sheet N°311. Geneva, Switzerland: WHO; 2006.
2. World Health Organization. Cancer-Fact Sheet N°297. Geneva, Switzerland: WHO; 2009.
3. Global Alliance for the Prevention of Obesity and Related Chronic Disease. 2008.
4. International Union Against Cancer-(UICC). World Cancer Declaration (). 2008.
5. Colquitt JL, Picot J, Loveman E, Clegg AJ., Surgery for obesity. Cochrane Database Syst Rev. 2009:CD003641.
6. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351: 2683-2693. (Pubitemid 39665322)
7. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357: 741-752. (Pubitemid 47295641)
8. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292: 1724-1737. (Pubitemid 39346675)
9. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122: 248 -256. e5.
10. Ashrafian H, Athanasiou T, Li JV, et al. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass [published online ahead of print September 29, 2010]. Obes Rev. doi: 10.1111/j.1467-789X.2010. 00802.x
11. Ashrafian H, Bueter M, Ahmed K, et al. Metabolic surgery: an evolution through bariatric animal models [published online ahead of print December 29, 2010]. Obes Rev. PMID: 20051020
12. Ashrafian H, le Roux CW., Metabolic surgery and gut hormones-a review of bariatric entero-humoral modulation. Physiol Behav. 2009; 97: 620-631.
13. Ashrafian H, le Roux CW, Darzi A, Athanasiou T., Effects of bariatric surgery on cardiovascular function. Circulation. 2008; 118: 2091-2102.
14. Rubino F, R';Bibo SL, del Genio F, Mazumdar M, McGraw TE., Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010; 6: 102-109.
15. Calle EE, Kaaks R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-591. (Pubitemid 39025053)
16. Ahn J, Schatzkin A, Lacey JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007; 167: 2091-2102. (Pubitemid 350036709)
17. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007; 357: 753-761. (Pubitemid 47295642)
18. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009; 17: 796-802.
19. Sjostrom L, Gummesson A, Sjostrom CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol. 2009; 10: 653-662.
20. Renehan AG., Bariatric surgery, weight reduction, and cancer prevention. Lancet Oncol. 2009; 10: 640-641.
21. Ashrafian H., Familial proptosis and obesity in the Ptolemies. J R Soc Med. 2005; 98: 85-86.
22. Hoffman FL., The menace of cancer. Am J Obstet Dis Women Child. 1913; 68: 88-91.
23. Tannenbaum A., Relationship of body weight to cancer incidence. Arch Pathol. 1940; 30: 509.
24. Garfinkel L., Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Monogr. 1985; 67: 49-52. (Pubitemid 15031260)
25. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D., Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335: 1134.
26. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371: 569-578. (Pubitemid 351232031)
27. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009; 373: 1083-1096.
28. World Cancer Research Fund/American Institute for Cancer. Second Expert Report: Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. WCRF; 2007.
29. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003; 348: 1625-1638. (Pubitemid 36459468)
30. Parker ED, Folsom AR., Intentional weight loss and incidence of obesity-related cancers: the Iowa Women';s Health Study. Int J Obes Relat Metab Disord. 2003; 27: 1447-1452. (Pubitemid 38019155)
31. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299: 316-323. (Pubitemid 351159368)
32. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009; 374: 1677-1686.
33. O'Brien PE, McPhail T, Chaston TB, Dixon JB., Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006; 16: 1032-1040. (Pubitemid 44221269)
34. Sabbagh C, Verhaeghe P, Dhahri A, et al. Two-year results on morbidity, weight loss and quality of life of sleeve gastrectomy as first procedure, sleeve gastrectomy after failure of gastric banding and gastric banding. Obes Surg. 2010; 20: 679-684.
35. Buchwald H, Oien DM., Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009; 19: 1605-1611.
36. Yokoyama M, Kitamura Y, Kohrogi T, Miyoshi I., Necessity of bile for and lack of inhibitory effect of retinoid on development of forestomach papillomas in nontreated mutant mice of the W/Wv genotype. Cancer Res. 1982; 42: 3806-3809. (Pubitemid 12054499)
37. Miwa K, Hattori T, Miyazaki I., Duodenogastric reflux and foregut carcinogenesis. Cancer. 1995; 75 (6 suppl): 1426-1432.
38. Griffen WO Jr, Young VL, Stevenson CC., A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977; 186: 500-509. (Pubitemid 8197682)
39. Inoue H, Rubino F, Shimada Y, et al. Risk of gastric cancer after Roux-en-Y gastric bypass. Arch Surg. 2007; 142: 947-953. (Pubitemid 47607601)
40. Nishijima K, Miwa K, Miyashita T, et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett';s esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg. 2004; 240: 57-67. (Pubitemid 38808235)
41. Ahmed K, Wang TT, Patel VM, et al. The role of single-incision laparoscopic surgery in abdominal and pelvic surgery: a systematic review [published online ahead of print July 10, 2010]. Surg Endosc. PMID: 20623239
42. Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361: 445-454.
43. Cohen R, Pinheiro JS, Correa JL, Schiavon CA., Laparoscopic Roux-en-Y gastric bypass for BMI <35 kg/m(2): a tailored approach. Surg Obes Relat Dis. 2006; 2: 401-404. (Pubitemid 43812096)
44. Omalu BI, Ives DG, Buhari AM, et al. Death rates and causes of death after bariatric surgery for Pennsylvania residents, 1995 to 2004. Arch Surg. 2007; 142: 923-928. (Pubitemid 47607597)
45. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C., Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years. Am J Epidemiol. 1999; 149: 491-503. (Pubitemid 29130016)
46. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T., Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000; 23: 1499-1504.
47. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004; 240: 416-423.
48. MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997; 1: 213-220. (Pubitemid 127432762)
49. Flum DR, Dellinger EP., Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004; 199: 543-551. (Pubitemid 39420204)
50. Peeters A, O'Brien PE, Laurie C, et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg. 2007; 246: 1028-1033. (Pubitemid 350179196)
51. Sowemimo OA, Yood SM, Courtney J, et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis. 2007; 3: 73-77. (Pubitemid 46112406)
52. Busetto L, Mirabelli D, Petroni ML, et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis. 2007; 3: 496-502. (Pubitemid 47454437)
53. Christou NV, Lieberman M, Sampalis F, Sampalis JS., Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008; 4: 691-695.
54. Johnson CH, Adamo M,. SEER Program Coding and Staging Manual 2007 (NIH Publication number 07-5581, 2008 revision). Bethesda, MD: National Cancer Institute; 2007.
55. McCawley GM, Ferriss JS, Geffel D, Northup CJ, Modesitt SC., Cancer in obese women: potential protective impact of bariatric surgery. J Am Coll Surg. 2009; 208: 1093-1098.
56. Boru C, Silecchia G, Pecchia A, et al. Prevalence of cancer in Italian obese patients referred for bariatric surgery. Obes Surg. 2005; 15: 1171-1176. (Pubitemid 41390217)
57. Cummings DE, Flum DR., Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008; 299: 341-343. (Pubitemid 351159373)
58. Galtier F, Farret A, Verdier R, et al. Resting energy expenditure and fuel metabolism following laparoscopic adjustable gastric banding in severely obese women: relationships with excess weight lost. Int J Obes (Lond). 2006; 30: 1104-1110. (Pubitemid 43980580)
59. Scruggs DM, Buffington C, Cowan GS Jr., Taste acuity of the morbidly obese before and after gastric bypass surgery. Obes Surg. 1994; 4: 24-28. (Pubitemid 24063790)
60. Madan AK, Tichansky DS, Phillips JC., Does pouch size matter? Obes Surg. 2007; 17: 317-320. (Pubitemid 46659290)
61. Li J, Feuers RJ, Desai VG, et al. Surgical caloric restriction ameliorates mitochondrial electron transport dysfunction in obese females. Obes Surg. 2007; 17: 800-808. (Pubitemid 46999046)
62. Olbers T, Bjorkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006; 244: 715-722. (Pubitemid 44629945)
63. Moreschi C., Beziehungen zwischen Ernahrung und Tumorwachstum. Z Immunitatsforsch. 1909; 2: 661-675.
64. Rous P., The influence of diet on transplanted and spontaneous mouse tumors. J Exp Med. 1914; 20: 433-451.
65. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN., Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010; 31: 83-89.
66. Livhits M, Mercado C, Yermilov I, et al. Exercise following bariatric surgery: systematic review. Obes Surg. 2010; 20: 657-665.
67. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA., Physical activity and survival after breast cancer diagnosis. JAMA. 2005; 293: 2479-2486. (Pubitemid 40705729)
68. Meyerhardt JA, Giovannucci EL, Ogino S, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009; 169: 2102-2108.
69. Coussens LM, Werb Z., Inflammation and cancer. Nature. 2002; 420: 860-867. (Pubitemid 36019639)
70. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006; 17: 4-12.
71. Olefsky JM., IKKepsilon: a bridge between obesity and inflammation. Cell. 2009; 138: 834-836.
72. de Visser KE, Eichten A, Coussens LM., Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006; 6: 24-37. (Pubitemid 43053650)
73. Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005; 90: 316-322. (Pubitemid 40116674)
74. Uzun H, Zengin K, Taskin M, Aydin S, Simsek G, Dariyerli N., Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004; 14: 659-665. (Pubitemid 38716588)
75. Holdstock C, Lind L, Engstrom BE, et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes (Lond). 2005; 29: 1275-1280. (Pubitemid 43080308)
76. Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AF, Schernthaner G., Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond). 2005; 29: 766-771. (Pubitemid 40897012)
77. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003; 23: 1042-1047. (Pubitemid 36713558)
78. Moulin CM, Marguti I, Peron JP, Halpern A, Rizzo LV., Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity [published online ahead of print August 28, 2010]. Obes Surg. PMID: 20803097.
79. Zamai L, Ponti C, Mirandola P, et al. NK cells and cancer. J Immunol. 2007; 178: 4011-4016. (Pubitemid 46492347)
80. Huang PL., A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2: 231-237.
81. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F., Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev. 2001; 10: 937-941. (Pubitemid 32844900)
82. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K., Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002; 11: 385-391. (Pubitemid 34408218)
83. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM., Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293: 194-202. (Pubitemid 40095870)
84. Hewish M, Chau I, Cunningham D., Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine. Recent Pat Anticancer Drug Discov. 2009; 4: 54-72.
85. Engelman JA, Luo J, Cantley LC., The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006; 7: 606-619. (Pubitemid 44100518)
86. Rosen LS., VEGF-targeted therapy: therapeutic potential and recent advances. Oncologist. 2005; 10: 382-391. (Pubitemid 40993566)
87. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS., Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg. 2005; 15: 474-481. (Pubitemid 40605068)
88. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003; 238: 467-484.
89. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222: 339-350.
90. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005; 353: 249-254. (Pubitemid 41058324)
91. Polesel J, Zucchetto A, Montella M, et al. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol. 2009; 20: 353-357.
92. Oliveira CP, Faintuch J, Rascovski A, et al. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD)-preliminary findings. Obes Surg. 2005; 15: 502-505. (Pubitemid 40605073)
93. Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM., Obesity and hepatocellular carcinoma. Gastroenterology. 2004; 127 (5 suppl 1): S97-S103. (Pubitemid 39423375)
94. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK., Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008; 6: 1396-1402.
95. Kisakol G, Guney E, Bayraktar F, Yilmaz C, Kabalak T, Ozmen D., Effect of surgical weight loss on free radical and antioxidant balance: a preliminary report. Obes Surg. 2002; 12: 795-800. (Pubitemid 36135522)
96. Fenton JI, Hord NG, Lavigne JA, Perkins SN, Hursting SD., Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1646-1652. (Pubitemid 40995074)
97. Cao L, Liu X, Lin EJ, et al. Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition. Cell. 2010; 142: 52-64.
98. Brakenhielm E, Veitonmaki N, Cao R, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004; 101: 2476-2481. (Pubitemid 38269336)
99. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E., Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis. 2009; 24: 275-281.
100. Sun CA, Wu MH, Chu CH, et al. Adipocytokine resistin and breast cancer risk. Breast Cancer Res Treat. 2010; 123: 869-876.
101. Nijhuis J, van Dielen FM, Buurman WA, Greve JW., Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg. 2004; 14: 783-787. (Pubitemid 38982263)
102. Pender C, Goldfine ID, Tanner CJ, et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int J Obes Relat Metab Disord. 2004; 28: 363-369. (Pubitemid 38296948)
103. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004; 12: 962-971.
104. Eliassen AH, Hankinson SE., Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008; 630: 148-165.
105. Song RX, Fan P, Yue W, Chen Y, Santen RJ., Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer. Endocr Relat Cancer. 2006; 13 suppl 1: S3-S13. (Pubitemid 46219244)
106. Hammoud A, Gibson M, Hunt SC, et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009; 94: 1329-1332.
107. Morisset AS, Blouin K, Tchernof A., Impact of diet and adiposity on circulating levels of sex hormone-binding globulin and androgens. Nutr Rev. 2008; 66: 506-516.
108. Leontiou CA, Franchi G, Korbonits M., Ghrelin in neuroendocrine organs and tumours. Pituitary. 2007; 10: 213-225. (Pubitemid 350055032)
109. Nikolopoulos D, Theocharis S, Kouraklis G., Ghrelin';s role on gastrointestinal tract cancer. Surg Oncol. 2010; 19: e2-e10.
110. Lanfranco F, Baldi M, Cassoni P, Bosco M, Ghe C, Muccioli G., Ghrelin and prostate cancer. Vitam Horm. 2008; 77: 301-324.
111. Vincent RP, Ashrafian H, le Roux CW., Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol. 2008; 5: 268-277. (Pubitemid 351637912)
112. Guijarro A, Osei-Hyiaman D, Harvey-White J, et al. Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function. Ann Surg. 2008; 247: 779-790. (Pubitemid 351591513)
113. Ashrafian H., Cancer';s sweet tooth: the Janus effect of glucose metabolism in tumorigenesis. Lancet. 2006; 367: 618-621. (Pubitemid 43247576)
114. Mithieux G., A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition. 2009; 25: 881-884.
115. Stylopoulos N, Hoppin AG, Kaplan LM., Roux-en-Y gastric bypass enhances energy expenditure and extends lifespan in diet-induced obese rats. Obesity (Silver Spring). 2009; 17: 1839-1847.
116. Madan AK., Metabolic surgery: not just weight loss surgery anymore. Surg Obes Relat Dis. 2009; 5: 18-19.
117. DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008; 22: 706-716. (Pubitemid 351341683)
118. Ashrafian H, Darzi A, Athanasiou T., Autobionics: a new paradigm in regenerative medicine and surgery. Regen Med. 2010; 5: 279-288.